Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Aria F. Olumi, M.D.

Co-Author

This page shows the publications co-authored by Aria Olumi and Chin-Lee Wu.
Connection Strength

3.082
  1. Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder. N Engl J Med. 2013 Aug 15; 369(7):660-7.
    View in: PubMed
    Score: 0.531
  2. Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy. PLoS One. 2020; 15(3):e0229754.
    View in: PubMed
    Score: 0.209
  3. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis. Scand J Urol. 2019 Oct; 53(5):287-294.
    View in: PubMed
    Score: 0.201
  4. Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy. Int Urol Nephrol. 2019 Sep; 51(9):1527-1535.
    View in: PubMed
    Score: 0.199
  5. Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome. Clin Genitourin Cancer. 2019 Feb; 17(1):e44-e52.
    View in: PubMed
    Score: 0.188
  6. Expression of aromatase in tumor related stroma is associated with human bladder cancer progression. Cancer Biol Ther. 2018 03 04; 19(3):175-180.
    View in: PubMed
    Score: 0.180
  7. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5a-reductase 2. J Pathol. 2017 12; 243(4):457-467.
    View in: PubMed
    Score: 0.179
  8. Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells. Oncotarget. 2015 Oct 06; 6(30):28973-87.
    View in: PubMed
    Score: 0.154
  9. Age and Obesity Promote Methylation and Suppression of 5a-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia. J Urol. 2015 Oct; 194(4):1031-7.
    View in: PubMed
    Score: 0.149
  10. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma. Hum Pathol. 2015 Jun; 46(6):820-6.
    View in: PubMed
    Score: 0.148
  11. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate. Am J Pathol. 2015 Mar; 185(3):870-82.
    View in: PubMed
    Score: 0.147
  12. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am J Surg Pathol. 2012 Jun; 36(6):838-43.
    View in: PubMed
    Score: 0.122
  13. A close surgical margin after radical prostatectomy is an independent predictor of recurrence. J Urol. 2012 Jul; 188(1):91-7.
    View in: PubMed
    Score: 0.122
  14. Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol. 2013 Oct; 31(7):1033-7.
    View in: PubMed
    Score: 0.119
  15. Reduced levels of 5-a reductase 2 in adult prostate tissue and implications for BPH therapy. Prostate. 2011 Sep; 71(12):1317-24.
    View in: PubMed
    Score: 0.111
  16. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. Am J Pathol. 2007 Oct; 171(4):1189-98.
    View in: PubMed
    Score: 0.088
  17. Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland. Prostate Cancer Prostatic Dis. 2020 09; 23(3):465-474.
    View in: PubMed
    Score: 0.052
  18. Metabolomic Prediction of Human Prostate Cancer Aggressiveness: Magnetic Resonance Spectroscopy of Histologically Benign Tissue. Sci Rep. 2018 03 26; 8(1):4997.
    View in: PubMed
    Score: 0.046
  19. PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene. 2018 05; 37(21):2793-2805.
    View in: PubMed
    Score: 0.046
  20. Models of care and NCCN guideline adherence in very-low-risk prostate cancer. J Natl Compr Canc Netw. 2013 Nov; 11(11):1364-72.
    View in: PubMed
    Score: 0.034
  21. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012 Sep 01; 30(25):3071-6.
    View in: PubMed
    Score: 0.031
  22. Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension. Urology. 2011 Jul; 78(1):121-5.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.